Cargando…

A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis

BACKGROUND: Hepatic encephalopathy (HE) is a frequent and severe complication of cirrhosis. A single determination of ammonia in venous blood correlates poorly with neurological symptoms. Thus, a better biological marker is needed. AIM: To make a diagnosis of HE, we explored the value of ammonia in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ditisheim, Saskia, Giostra, Emiliano, Burkhard, Pierre R, Goossens, Nicolas, Mentha, Gilles, Hadengue, Antoine, Spahr, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253684/
https://www.ncbi.nlm.nih.gov/pubmed/22151412
http://dx.doi.org/10.1186/1471-230X-11-134
_version_ 1782220762064617472
author Ditisheim, Saskia
Giostra, Emiliano
Burkhard, Pierre R
Goossens, Nicolas
Mentha, Gilles
Hadengue, Antoine
Spahr, Laurent
author_facet Ditisheim, Saskia
Giostra, Emiliano
Burkhard, Pierre R
Goossens, Nicolas
Mentha, Gilles
Hadengue, Antoine
Spahr, Laurent
author_sort Ditisheim, Saskia
collection PubMed
description BACKGROUND: Hepatic encephalopathy (HE) is a frequent and severe complication of cirrhosis. A single determination of ammonia in venous blood correlates poorly with neurological symptoms. Thus, a better biological marker is needed. AIM: To make a diagnosis of HE, we explored the value of ammonia in capillary blood, an equivalent to arterial blood, measured at bedside following an oral glutamine challenge. METHODS: We included 57 patients (age 56 yrs; M/F: 37/20) with cirrhosis (alcoholic = 42; MELD score 13.8 [7-29], esophageal varices = 38) and previous episodes of HE (n = 19), but without neurological deficits at time of examination, and 13 healthy controls (age 54 yrs). After psychometric tests and capillary (ear lobe) blood ammonia measurements, 20 gr of glutamine was administered orally. Tests were repeated at 60 minutes (+ blood ammonia at 30'). Minimal HE was diagnosed if values were > 1.5 SD in at least 2 psychometric tests. Follow-up lasted 12 months. RESULTS: The test was well tolerated (nausea = 1; dizziness = 1). Patients showed higher values of capillary blood ammonia over time as compared to controls (0'-30'-60 minutes: 75, 117, 169 versus 52, 59, 78 umol/L, p < 0.05). At baseline, 25 patients (44%) had minimal HE, while 38 patients (67%) met the criteria for HE at 60 minutes (chi(2): p < 0.01). For the diagnosis of minimal HE, using the ROC curve analysis, baseline capillary blood ammonia showed an AUC of 0.541 (CI: 0.38-0.7, p = 0.6), while at 60 minutes the AUC was 0.727 (CI: 0.58-0.87, p < 0.006). During follow-up, 18 patients (31%) developed clinical episodes of HE. At multivariate analysis, the MELD score (1.12 [1.018-1.236]), previous episodes of HE (3.2[1.069-9.58]), but not capillary blood ammonia, were independent predictors of event. CONCLUSIONS: In patients with cirrhosis and normal neurological examination, bedside determination of ammonia in capillary blood following oral glutamine load is well tolerated and achieves a better diagnostic performance for minimal HE than basal capillary ammonia levels. However, capillary blood ammonia is a poor predictor of development of clinically overt HE.
format Online
Article
Text
id pubmed-3253684
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32536842012-01-10 A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis Ditisheim, Saskia Giostra, Emiliano Burkhard, Pierre R Goossens, Nicolas Mentha, Gilles Hadengue, Antoine Spahr, Laurent BMC Gastroenterol Research Article BACKGROUND: Hepatic encephalopathy (HE) is a frequent and severe complication of cirrhosis. A single determination of ammonia in venous blood correlates poorly with neurological symptoms. Thus, a better biological marker is needed. AIM: To make a diagnosis of HE, we explored the value of ammonia in capillary blood, an equivalent to arterial blood, measured at bedside following an oral glutamine challenge. METHODS: We included 57 patients (age 56 yrs; M/F: 37/20) with cirrhosis (alcoholic = 42; MELD score 13.8 [7-29], esophageal varices = 38) and previous episodes of HE (n = 19), but without neurological deficits at time of examination, and 13 healthy controls (age 54 yrs). After psychometric tests and capillary (ear lobe) blood ammonia measurements, 20 gr of glutamine was administered orally. Tests were repeated at 60 minutes (+ blood ammonia at 30'). Minimal HE was diagnosed if values were > 1.5 SD in at least 2 psychometric tests. Follow-up lasted 12 months. RESULTS: The test was well tolerated (nausea = 1; dizziness = 1). Patients showed higher values of capillary blood ammonia over time as compared to controls (0'-30'-60 minutes: 75, 117, 169 versus 52, 59, 78 umol/L, p < 0.05). At baseline, 25 patients (44%) had minimal HE, while 38 patients (67%) met the criteria for HE at 60 minutes (chi(2): p < 0.01). For the diagnosis of minimal HE, using the ROC curve analysis, baseline capillary blood ammonia showed an AUC of 0.541 (CI: 0.38-0.7, p = 0.6), while at 60 minutes the AUC was 0.727 (CI: 0.58-0.87, p < 0.006). During follow-up, 18 patients (31%) developed clinical episodes of HE. At multivariate analysis, the MELD score (1.12 [1.018-1.236]), previous episodes of HE (3.2[1.069-9.58]), but not capillary blood ammonia, were independent predictors of event. CONCLUSIONS: In patients with cirrhosis and normal neurological examination, bedside determination of ammonia in capillary blood following oral glutamine load is well tolerated and achieves a better diagnostic performance for minimal HE than basal capillary ammonia levels. However, capillary blood ammonia is a poor predictor of development of clinically overt HE. BioMed Central 2011-12-08 /pmc/articles/PMC3253684/ /pubmed/22151412 http://dx.doi.org/10.1186/1471-230X-11-134 Text en Copyright ©2011 Ditisheim et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ditisheim, Saskia
Giostra, Emiliano
Burkhard, Pierre R
Goossens, Nicolas
Mentha, Gilles
Hadengue, Antoine
Spahr, Laurent
A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
title A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
title_full A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
title_fullStr A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
title_full_unstemmed A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
title_short A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
title_sort capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253684/
https://www.ncbi.nlm.nih.gov/pubmed/22151412
http://dx.doi.org/10.1186/1471-230X-11-134
work_keys_str_mv AT ditisheimsaskia acapillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT giostraemiliano acapillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT burkhardpierrer acapillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT goossensnicolas acapillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT menthagilles acapillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT hadengueantoine acapillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT spahrlaurent acapillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT ditisheimsaskia capillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT giostraemiliano capillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT burkhardpierrer capillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT goossensnicolas capillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT menthagilles capillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT hadengueantoine capillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis
AT spahrlaurent capillarybloodammoniabedsidetestfollowingglutamineloadtoimprovethediagnosisofhepaticencephalopathyincirrhosis